| __timestamp | Ionis Pharmaceuticals, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 47795223 |
| Thursday, January 1, 2015 | 322292000 | 50426000 |
| Friday, January 1, 2016 | 344320000 | 70853000 |
| Sunday, January 1, 2017 | 374644000 | 78168000 |
| Monday, January 1, 2018 | 414604000 | 123757000 |
| Tuesday, January 1, 2019 | 466000000 | 140963000 |
| Wednesday, January 1, 2020 | 535000000 | 131773000 |
| Friday, January 1, 2021 | 643000000 | 210328000 |
| Saturday, January 1, 2022 | 833000000 | 235780000 |
| Sunday, January 1, 2023 | 899625000 | 244990000 |
| Monday, January 1, 2024 | 901530000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc. have shown distinct approaches to research and development (R&D) spending over the past decade. From 2014 to 2023, Ionis Pharmaceuticals consistently invested more in R&D, with a notable increase of approximately 272% over this period. In contrast, Travere Therapeutics increased its R&D spending by around 413%, albeit from a smaller base. By 2023, Ionis's R&D expenses were nearly four times that of Travere's, highlighting its commitment to innovation. This trend underscores the strategic priorities of these companies, with Ionis focusing heavily on pioneering new treatments, while Travere is rapidly scaling its efforts. As the pharmaceutical landscape evolves, these investments could be pivotal in shaping future breakthroughs.
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. or Verona Pharma plc: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
R&D Spending Showdown: Ionis Pharmaceuticals, Inc. vs MorphoSys AG
Research and Development Investment: Ionis Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Novavax, Inc.
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs Xencor, Inc.
Research and Development Expenses Breakdown: Xenon Pharmaceuticals Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Travere Therapeutics, Inc. and Viridian Therapeutics, Inc.
R&D Insights: How Travere Therapeutics, Inc. and MiMedx Group, Inc. Allocate Funds